Literature DB >> 31826636

ERAS protocol in gynecologic oncology.

S Bajsová, J Klát.   

Abstract

OBJECTIVE: To summarize current knowledge of the ERAS protocol in gynecologic oncology surgery.
DESIGN: Review article. SETTINGS: Department of Obstetrics and Gynecology, University Hospital Ostrava, Ostrava, Department of Obstetrics and Gynecology, University of Ostrava, Ostrava.
METHODS: Literature review, PubMed and Medline databases were used to search relevant literature from 1995 to 2019.
CONCLUSION: ERAS (Enhanced Recovery after Surgery) is a perioperative treatment program based on evidence-based medicine. Guidelines consist of pre-operative, perioperative and post-operative care items. Implementation of the ERAS protocol leads to a decrease in complications up to 40% and a reduction in hospitalization by up to 30%, thereby reducing overall costs without increasing the number of rehospitalizations. Multidisciplinary cooperation not only with anesthesiologists and consultant surgeons, but also with nutritional specialists and nurses is crucial.

Keywords:  ERAS protocol; gynecologic oncology surgery; perioperative care

Mesh:

Year:  2019        PMID: 31826636

Source DB:  PubMed          Journal:  Ceska Gynekol        ISSN: 1210-7832


  3 in total

1.  A steady stream of knowledge: decreased urinary retention after implementation of ERAS protocols in ambulatory minimally invasive inguinal hernia repair.

Authors:  Ryan C Broderick; Jonathan Z Li; Rachel R Blitzer; Pranav Ahuja; Alice Race; Gene Yang; Bryan J Sandler; Santiago Horgan; Garth R Jacobsen
Journal:  Surg Endosc       Date:  2022-01-04       Impact factor: 3.453

2.  Discussion of the experience and improvement of an enhanced recovery after surgery procedure for minimally invasive lobectomy: a cohort study.

Authors:  Haoxiang Ni; Peng Li; Zhe Meng; Tianwei Huang; Liang Shi; Bin Ni
Journal:  Ann Transl Med       Date:  2021-12

3.  ERAS vs. Traditional Protocol in Patients Who Had Radical Cystectomy with Ileal Conduit: A Retrospective Comparative Analysis of 182 Cases.

Authors:  Ahmet Semih Guleser; Yasar Basaga
Journal:  Adv Urol       Date:  2022-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.